Digitisation | August 02, 2023
Syrma SGS acquires majority sake in Johari Digital Healthcare
JDHL has a strong reputation as an end-to-end design-focused manufacturer of electro-medical devices
JDHL has a strong reputation as an end-to-end design-focused manufacturer of electro-medical devices
Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy
Proposed acquisition represents meaningful step forward in Biogen’s strategy for sustainable growth
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24
Erdafitinib is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma
Shivalik Rasayan Limited has issued LOA to Medicamen Biotech to use its DMF grade Bortezomib API for formulation of Bortezomib injection 3.5mg/ vial
Deal includes DTx-1252, a potential therapy for the neuromuscular disorder Charcot-Marie-Tooth disease type 1A (CMT1A), and two additional preclinical programs for other neuroscience indications
This product will be launched through Granules Consumer Health (GCH) division
USFDA concludes inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad
The company has submitted marketing authorization applications for mRNA-1345 with the European Medicines Agency (EMA), Swissmedic in Switzerland, and the Therapeutic Goods Administration (TGA) in Australia
Subscribe To Our Newsletter & Stay Updated
